Venus Remedies Limited (NSE:VENUSREM)
1,634.90
-8.80 (-0.54%)
Sep 24, 2026, 2:44 PM IST
Venus Remedies Employees
Venus Remedies had 1,472 employees as of March 31, 2026. The number of employees increased by 174 or 13.41% compared to the previous year.
Employees
1,472
Change (1Y)
174
Growth (1Y)
13.41%
Revenue / Employee
5.51M INR
Profits / Employee
789.06K INR
Market Cap
22.00B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 1,472 | 174 | 13.41% |
| Mar 31, 2025 | 1,298 | 111 | 9.35% |
| Mar 31, 2024 | 1,187 | 189 | 18.94% |
| Mar 31, 2023 | 998 | 56 | 5.94% |
| Mar 31, 2022 | 942 | 105 | 12.54% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Solara Active Pharma Sciences | 1,669 |
| Sigachi Industries | 1,400 |
| Ind-Swift Laboratories | 1,388 |
| Windlas Biotech | 1,385 |
| RPG Life Sciences | 1,366 |
| Jagsonpal Pharmaceuticals | 1,297 |
| Orchid Pharma | 1,169 |
Venus Remedies News
- 2 months ago - Venus Remedies announces special window for re-lodgement of physical share transfers - Business Upturn
- 3 months ago - Venus Remedies urges shareholders to update KYC details via social media - Business Upturn
- 3 months ago - Venus Remedies secures renewal of DSIR in-house R&D recognition - Business Upturn
- 4 months ago - Venus Remedies hits 5% upper circuit at all-time high as FY26 profit more than doubles to ₹102.78 crore - Business Upturn
- 4 months ago - Venus Remedies announces ₹10 per share final dividend with record date set for August 2026 - Business Upturn
- 4 months ago - Venus Remedies schedules AGM for August 2026 and announces dividend - Business Upturn
- 4 months ago - Venus Remedies shares rally 4% after Saudi Arabia approves oncology drug Plerixafor for global marketing authorization - Business Upturn
- 4 months ago - Venus Remedies receives Saudi FDA approval for Plerixafor - Business Upturn